FDA Approved: ADEFOVIR DIPIVOXIL — Original Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved the original ANDA for Adefovir dipivoxil from Sigmapharm Laboratories, LLC, enabling generic manufacture of this antiviral for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

ORIG AP for ADEFOVIR DIPIVOXIL (ADEFOVIR DIPIVOXIL)